Conference Coverage

Cardiology
Cardiology
10/19/2017
In The Role of SGLT-2 Inhibitors in the Management of T2DM," Anne L Peters, MD, details treatment with empagliflozin and canagliflozin and its effects on outcomes including blood pressure, CV death,...
10/19/2017
Cardiology
Cardiology
10/19/2017
In The Role of SGLT-2 Inhibitors in the Management of T2DM," Anne L Peters, MD, details treatment with empagliflozin and canagliflozin and its effects on outcomes including blood pressure, CV death,...
10/19/2017
Cardiology
Cardiology
10/19/2017
In The Role of SGLT-2 Inhibitors in the Management of T2DM," Anne L Peters, MD, details treatment with empagliflozin and canagliflozin and its effects on outcomes including blood pressure, CV death,...
10/19/2017
Cardiometabolic risk
Cardiometabolic risk
10/19/2017
Deborah Bade Horn, DO, MPH, FOMA, will present “How to Help Your Patients Lead a Physically Active Life” today at the Cardiometabolic Risk Summit. In her presentation, she will discuss how to best prescribe...
10/19/2017
Cardiometabolic risk
Cardiometabolic risk
10/19/2017
Deborah Bade Horn, DO, MPH, FOMA, will present “How to Help Your Patients Lead a Physically Active Life” today at the Cardiometabolic Risk Summit. In her presentation, she will discuss how to best prescribe...
10/19/2017
Cardiometabolic risk
Cardiometabolic risk
10/19/2017
Deborah Bade Horn, DO, MPH, FOMA, will present “How to Help Your Patients Lead a Physically Active Life” today at the Cardiometabolic Risk Summit. In her presentation, she will discuss how to best prescribe...
10/19/2017
Cardiometabolic risk
Cardiometabolic risk
10/19/2017
Consultant360 recently spoke with Dr Eileen O’Grady, who will be presenting at the Cardiometabolic Risk Summit about how physicians can motivate their patients to lower their cardiometabolic risk through...
10/19/2017
Cardiometabolic risk
Cardiometabolic risk
10/19/2017
Consultant360 recently spoke with Dr Eileen O’Grady, who will be presenting at the Cardiometabolic Risk Summit about how physicians can motivate their patients to lower their cardiometabolic risk through...
10/19/2017
Cardiometabolic risk
Cardiometabolic risk
10/19/2017
Consultant360 recently spoke with Dr Eileen O’Grady, who will be presenting at the Cardiometabolic Risk Summit about how physicians can motivate their patients to lower their cardiometabolic risk through...
10/19/2017
inflammatory bowel disease
inflammatory bowel disease
10/16/2017
Inflammatory bowel disease has evolved into a global disease in the 21st century. In a recent systematic review, researchers evaluated the incidence of inflammatory bowel disease in different regions of the...
10/16/2017